Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deoxycholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel esterification-crystallization method removes double oxide impurities, ensuring superior quality for ursodeoxycholic acid production.
Patent CN113024624A details a novel 8-step synthesis of deoxycholic acid from cholic acid, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Advanced synthesis of Chenodeoxycholic Acid via hypochlorite oxidation. High yield, low cost route for API manufacturing. Reliable pharmaceutical intermediates supplier.
Patent CN119506235A reveals directed evolution for UDCA. Enhances supply chain stability and reduces manufacturing costs significantly.
Patent CN112588319A reveals a novel silane-catalyzed route for TUDCA synthesis, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102070693A details a high-yield chiral hydrogenation method for ursodeoxycholic acid, offering superior purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN107099516B reveals a stable 7β-hydroxysteroid dehydrogenase mutant enabling high-concentration ursodeoxycholic acid synthesis with superior thermal stability and simplified downstream processing.
Patent CN118745205A details a plant-derived ursodeoxycholic acid synthesis avoiding animal risks. Offers high purity and scalable supply chain solutions.
Patent CN118638174A reveals a plant-based UDCA synthesis route. Achieve 99.91% purity with reduced viral risk and scalable enzymatic steps for reliable supply.
Patent CN119119158A reveals a novel plant-derived route for ursodeoxycholic acid. Achieve high purity and cost reduction in API manufacturing with scalable bio-hybrid synthesis.
Patent CN105294809A reveals a novel two-step synthesis for high-purity Tauroursodeoxycholic Acid, eliminating toxic impurities and ensuring scalable pharmaceutical intermediate manufacturing.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Novel patent CN119462811A offers high-yield ursodeoxycholic acid synthesis with reduced steps and enhanced safety for reliable pharmaceutical intermediate supply chains.
Patent CN115181150A details a green synthesis of UDCA from phytosterol derivatives, offering high yield and reduced chromium pollution for reliable API intermediate supply.
Patent CN111328332A details a novel synthetic route for cholic and deoxycholic acid from plant-derived DHEA, ensuring high purity and eliminating animal-derived impurities for reliable supply chains.
Patent CN109402212B reveals a novel fusion enzyme method for TUDCA production, offering significant cost reduction in bile acid manufacturing and reliable supply chain scalability.
Patent CN119119158B reveals a novel plant-derived synthesis route for ursodeoxycholic acid offering significant supply chain stability and cost reduction advantages.
Patent CN116249536A reveals a novel batch production method for sodium taurodeoxycholate using isopropanol purification, offering high purity and simplified manufacturing for reliable supply chains.